calendar
6,520 catalysts · 3,590 8k filing · 1,000 device adverse event · 773 grant · 578 earnings · 220 approval · 172 phase 2 completion
6,520 catalysts · 3,590 8k filing · 1,000 device adverse event · 773 grant · 578 earnings · 220 approval · 172 phase 2 completion
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: SAGENT. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: CAPSULE. Route: ORAL
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: MERZ. Form: POWDER. Route: INHALATION
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION
Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: KLM LABS PVT. Form: ENEMA. Route: RECTAL
Product code: IOR. Advisory committee: Physical Medicine. Type: Traditional
Product code: LLZ. Advisory committee: Radiology. Type: Traditional
Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: FMK. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: FBK. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: OAS. Advisory committee: Radiology. Type: Special
Supplement type: Panel Track. Product code: LMH. Advisory committee: SU. Decision: APPR
Supplement type: 30-Day Notice. Product code: MGB. Advisory committee: CV. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: LMH. Advisory committee: SU. Decision: APPR
Insufficient Information
Appropriate Term/Code Not Available
Failure to Osseointegrate
Leak/Splash; Loose or Intermittent Connection
Patient-Device Incompatibility
Malposition of Device
Insufficient Information
Failure to Osseointegrate
Insufficient Information
Loss of Osseointegration
Insufficient Information
Failure to Osseointegrate; Migration
Failure to Osseointegrate
Collapse; Fluid/Blood Leak
Insufficient Information
Incorrect, Inadequate or Imprecise Result or Readings
Patient Device Interaction Problem
Low Readings
Insufficient Information
Adverse Event Without Identified Device or Use Problem